We are live on
!
Find out more
ACM
AlphaCrest Capital Management Portfolio holdings
AUM
$1.64B
1-Year Est. Return
23.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.62%
1 Year Est. Return
-23.4%
3 Year Est. Return
-8.44%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.69B
AUM Growth
+$757M
(+39%)
Cap. Flow
+$669M
Cap. Flow
% of AUM
24.84%
Top 10 Holdings %
Top 10 Hldgs %
7.15%
Holding
1,493
New
266
Increased
636
Reduced
447
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$25.2M |
| 2 |
Texas Instruments
TXN
|
+$20.4M |
| 3 |
Medtronic
MDT
|
+$17.8M |
| 4 |
Analog Devices
ADI
|
+$17.3M |
| 5 |
Yum China
YUMC
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$13.2M |
| 2 |
CERN
Cerner Corp
CERN
|
+$10.4M |
| 3 |
Abbott
ABT
|
+$7.92M |
| 4 |
Walt Disney
DIS
|
+$7.58M |
| 5 |
Crown Castle
CCI
|
+$7.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 13.23% |
| 5 | Consumer Discretionary | 11.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1301
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $241K | 0.01% |
+4,600
| New | +$193K |
|
1302
Carvana
CVNA
$72.7B
| $236K | 0.01% |
+5,090
| New | +$280K |
|
1303
Lincoln National
LNC
$8.82B
| $235K | 0.01% |
3,438
-9,575
| -74% | -$675K |
|
|
SRCL
1304
DELISTED
Stericycle Inc
SRCL
| $235K | 0.01% |
+3,941
| New | +$247K |
|
|
BKI
1305
DELISTED
Black Knight, Inc. Common Stock
BKI
| $232K | 0.01% |
2,800
-9,100
| -76% | -$679K |
|
1306
Whirlpool
WHR
$2.54B
| $231K | 0.01% |
+983
| New | +$216K |
|
1307
Kirby Corp
KEX
$6.98B
| $230K | 0.01% |
3,863
-18,321
| -83% | -$1.02M |
|
1308
Southern Company
SO
$107B
| $230K | 0.01% |
3,361
-4,552
| -58% | -$290K |
|
1309
Live Oak Bancshares
LOB
$2.03B
| $229K | 0.01% |
+2,625
| New | +$219K |
|
1310
Performance Food Group
PFGC
$18B
| $229K | 0.01% |
+4,995
| New | +$227K |
|
1311
Regenxbio
RGNX
$638M
| $229K | 0.01% |
+7,000
| New | +$238K |
|
1312
Mercury Systems
MRCY
$6.35B
| $226K | 0.01% |
4,100
-26,290
| -87% | -$1.33M |
|
1313
Anavex Life Sciences
AVXL
$273M
| $225K | 0.01% |
12,991
-1,409
| -10% | -$26.8K |
|
1314
LendingTree
TREE
$448M
| $225K | 0.01% |
1,839
+144
| +8% | +$19.1K |
|
|
CYBR
1315
DELISTED
CyberArk
CYBR
| $222K | 0.01% |
1,279
-1,020
| -44% | -$179K |
|
1316
Intellia Therapeutics
NTLA
$1.5B
| $222K | 0.01% |
+1,877
| New | +$235K |
|
1317
BRC Group Holdings
RILY
$301M
| $222K | 0.01% |
+2,500
| New | +$183K |
|
1318
Sensata Technologies
ST
$6.81B
| $222K | 0.01% |
3,604
-3,205
| -47% | -$187K |
|
1319
Calix
CALX
$2.35B
| $221K | 0.01% |
+2,763
| New | +$180K |
|
1320
Churchill Downs
CHDN
$5.82B
| $220K | 0.01% |
1,824
-5,866
| -76% | -$696K |
|
1321
NETGEAR
NTGR
$648M
| $220K | 0.01% |
+7,515
| New | +$224K |
|
1322
Cisco
CSCO
$457B
| $219K | 0.01% |
3,451
-121,187
| -97% | -$6.92M |
|
|
EB
1323
DELISTED
Eventbrite
EB
| $219K | 0.01% |
12,539
-39,861
| -76% | -$737K |
|
1324
Texas Roadhouse
TXRH
$13.8B
| $218K | 0.01% |
2,441
-4,840
| -66% | -$431K |
|
1325
TFI International
TFII
$11.1B
| $215K | 0.01% |
1,917
-2,183
| -53% | -$237K |
|
Similar funds
RHBC
BDF
SCA
IC
WFA
CA
RIG
CCP
AlphaCrest Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, AlphaCrest Capital Management held 1,493 positions worth $2.69B, up 39% from $1.93B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
AlphaCrest Capital Management deployed $669M of net new capital in Q4 2021, opening 266 new positions and adding to 636 existing holdings. Its largest new stake was Yum China: 269,184 shares worth $13.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $13.2M trimmed.
- AlphaCrest Capital Management's largest Q4 2021 buy was Yum China: 269,184 shares worth $13.4M.
- AlphaCrest Capital Management added most to Oracle in Q4 2021, an estimated $25.2M increase.
- AlphaCrest Capital Management's biggest Q4 2021 reduction was Union Pacific, cutting an estimated $13.2M.
- AlphaCrest Capital Management fully exited Cerner Corp in Q4 2021, selling an estimated $10.4M.
- AlphaCrest Capital Management's ten largest holdings make up 7.2% of its $2.69B portfolio in Q4 2021.
- AlphaCrest Capital Management opened 266 new positions and closed 143 in Q4 2021.
- AlphaCrest Capital Management's portfolio value rose 39% quarter-over-quarter to $2.69B.
Based on AlphaCrest Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.